WASHINGTON, March 12 (Reuters) - Compounded weight-loss drugs that contain vitamin B12 and the main ingredient in Eli Lilly's ...

Compounded versions of branded drugs are not approved by the U.S. FDA, but they are available to patients who require ...

Lilly is warning the public that tirzepatide mixed with B12 is creating an impurity with “unknown effects” in humans.

Eli Lilly said copycat versions of Zepbound that add B12 result in potentially dangerous impurities. The compounding industry ...

Though it’s hard to say exactly what the future holds for mass GLP-1 compounding, the pressure is mounting from multiple angles in the U.S. | Eli Lilly—which has already staged multiple efforts in ...

After years of fighting over compounded weight loss drugs, Hims & Hers and Novo Nordisk are teaming up to sell Ozempic and Wegovy — a shift that could raise costs for patients.

The FDA is taking no prisoners as it continues its efforts to combat widespread GLP-1 drug compounding. | In the letters sent ...

Shares of telehealth company Hims & Hers skyrocketed Monday after the company struck a deal with Danish drugmaker Novo Nordisk to sell its GLP-1 weight-loss medications, ending the feud between the ...

You’ve probably encountered compounded medications at some point. Maybe a pharmacy-made topical anesthetic or a customized rinse for a sensitive patient. Simply put, compounding means a pharmacist ...

When approved drugs do not exist for a species, condition or delivery route, compounded medications can fill the gap. These formulations provide new flexibility for managing livestock health.

Eli Lilly (NYSE:LLY) said compounded weight-loss treatments that combine vitamin B12 with the active ingredient used in its ...